Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of neuroimmunological diseases.

Literature DB >> 16998750

Epidemiology of neuroimmunological diseases.

Abstract

This review gives an overview of various neuroimmunological diseases in terms of incidence and prevalence rates, age and sex distribution, and the frequency of subtypes, if applicable. The disorders selected for review are inflammatory muscle disorders (polymyositis, dermatomyositis and inclusion body myositis), myasthenia gravis, immune-mediated polyneuropathies (Guillain-Barré syndrome, chronic polyneuritis and vasculitic neuropathies), and multiple sclerosis.

Entities: Disease

Mesh：

Year: 2006 PMID： 16998750 DOI： 10.1007/s00415-006-5001-3

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

51 in total

1. [Projection of the number of multiple sclerosis patients in Germany].

Authors: T Hein; W Hopfenmüller
Journal: Nervenarzt Date: 2000-04 Impact factor: 1.214

2. Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study.

Authors: T Hovi; M Stenvik
Journal: Bull World Health Organ Date: 2000 Impact factor: 9.408

3. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands.

Authors: R Van Koningsveld; P A Van Doorn; P I Schmitz; C W Ang; F G Van der Meché
Journal: Neurology Date: 2000-02-08 Impact factor: 9.910

4. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors: F D Lublin; S C Reingold
Journal: Neurology Date: 1996-04 Impact factor: 9.910

5. Guillain-Barré syndrome following influenza vaccination.

Authors: Penina Haber; Frank DeStefano; Fredrick J Angulo; John Iskander; Sean V Shadomy; Eric Weintraub; Robert T Chen
Journal: JAMA Date: 2004-11-24 Impact factor: 56.272

6. Chronic polyneuropathies in Vest-Agder, Norway.

Authors: A Mygland ; P Monstad
Journal: Eur J Neurol Date: 2001-03 Impact factor: 6.089

Review 7. Polymyositis and dermatomyositis.

Authors: Marinos C Dalakas; Reinhard Hohlfeld
Journal: Lancet Date: 2003-09-20 Impact factor: 79.321

8. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

Authors: H J Willison; J Veitch; G Paterson; P G Kennedy
Journal: J Neurol Neurosurg Psychiatry Date: 1993-02 Impact factor: 10.154

9. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Authors: T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen
Journal: N Engl J Med Date: 1998-12-17 Impact factor: 91.245

10. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors: L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal: Am J Epidemiol Date: 1979-08 Impact factor: 4.897

14 in total

1. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors: A V Kabanov; H E Gendelman
Journal: Prog Polym Sci Date: 2007 Impact factor: 29.190

Review 2. Diagnosis and management of autoimmune myasthenia gravis.

Authors: Corrado Angelini
Journal: Clin Drug Investig Date: 2011 Impact factor: 2.859

3. Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature.

Authors: P Claire Langdon; Kylie Mulcahy; Kelly L Shepherd; Vincent H Low; Frank L Mastaglia
Journal: Dysphagia Date: 2011-12-30 Impact factor: 3.438

4. Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.

Authors: Kelly A Langert; Bruktawit Goshu; Evan B Stubbs
Journal: J Neurochem Date: 2016-12-20 Impact factor: 5.372